We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies from this website. If you would like to change your preferences you may do so by following these instructions.

OK

Investor Relations

John Innes Centre Continues Retrofit with New Order of Heliospectra Intelligent Lighting Solutions

Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from the prestigious John Innes Centre in the UK. This order of ELIXIA and EOS lights complements the previous orders made by the customer and will be part of a new retrofitted glasshouse section fully run by Heliospectra’s helioCORE™ light control software. The order value is SEK 1.3 million (£ 113,600).

Heliospectra AB [HLSPY: OTCQB]
0.717 0.027 (3.91%)  01/18/2019 Delayed 15 minutes 
Open$0.67Daily Range$0.67-$0.717
Prev. Close$0.6952 Week Range$0.628-$1.20
Volume1,147  
Quote Data   Realtime
Inside Quote
BidAskLast Inside Change
$0.67 x 6000 shares$0.73 x 3100 shares01/18 5:00 PM EST
Level II Quote Montage
BID
ASK
MMIDBid PriceBid SizeDate/Time
NITE0.67600001/18
MCAP0.666100001/18
CANT0.66100001/18
ETRF0.655100001/18
INTL0.64100001/18
CSTI0.50250001/18
OTCXU01/18
CDELU01/18
MMIDAsk PriceAsk SizeDate/Time
CDEL0.73310001/18
NITE0.773100001/18
MCAP0.776100001/18
CANT0.81100001/18
ETRF0.83800001/18
INTL0.89100001/18
CSTI1.10185001/18
OTCXU01/18

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link

Subscribe to IR news

Language






By signing up, you agree to our GDPR policy

IR Contact

Ali Ahmadian

CEO

+46 (0)72 203 63 44
[email protected]